SouthState Corp’s Edwards Lifesciences EW Stock Holding History

SouthState Corp’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.14K	Buy	90 +17	+23%	+$1.42K	﹤0.01%	728
2026 Q1	$5.85K	Sell	73 -36	-33%	-$2.97K	﹤0.01%	739
2025 Q4	$9.29K	Sell	109 -10	-8%	-$821	﹤0.01%	698
2025 Q3	$9.26K	Sell	119 -248	-68%	-$19.4K	﹤0.01%	673
2025 Q2	$28.7K	Hold	367	–	–	﹤0.01%	587
2025 Q1	$26.6K	Buy	+367	New	+$26.3K	﹤0.01%	633
2023 Q3	–	Sell	-360	Closed	-$34K	–	644
2023 Q2	$34K	Hold	360	–	–	﹤0.01%	377
2023 Q1	$29.8K	Hold	360	–	–	﹤0.01%	405
2022 Q4	$26.9K	Sell	360 -73	-17%	-$5.63K	﹤0.01%	438
2022 Q3	$36K	Buy	433 +73	+20%	+$7.02K	﹤0.01%	414
2022 Q2	$34K	Buy	+360	New	+$37.3K	﹤0.01%	446

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

SouthState Corp's EW Position: Q2 2026 in Review

SouthState Corp increased its Edwards Lifesciences (EW) stake by 23% in Q2 2026, buying an estimated $1.42K and bringing the position to 90 shares worth $8.14K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

SouthState Corp first reported a position in EW in Q2 2022 and has held it in 11 quarters since. The position peaked at $36K in Q3 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

SouthState Corp held 90 shares of Edwards Lifesciences worth $8.14K as of Q2 2026.
SouthState Corp bought 17 Edwards Lifesciences shares in Q2 2026, an estimated $1.42K.
Edwards Lifesciences made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #728 holding.
SouthState Corp first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 11 quarters since.
SouthState Corp's Edwards Lifesciences position peaked at $36K in Q3 2022.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.